Viewing Study NCT05339204


Ignite Creation Date: 2025-12-24 @ 9:16 PM
Ignite Modification Date: 2026-06-02 @ 6:47 PM
Study NCT ID: NCT05339204
Status: RECRUITING
Last Update Posted: 2022-04-21
First Post: 2022-04-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Role of Allo-HSCT in MRD-negative Patients With AML Under the Age of 60 Years in the First Complete Remission
Sponsor: National Research Center for Hematology, Russia
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module